Structural interventions to prevent HIV/sexually transmitted disease: Are they cost-effective for women in the Southern United States?

Sexually Transmitted Diseases

Volumn 33, Issue 7 SUPPL., 2006, Pages

  Cohen, Deborah A ^a   Wu, Shin Yi ^a   Farley, Thomas A ^b  

^a RAND CORPORATION   (United States)

^b TULANE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL CONSUMPTION; ARTICLE; BEHAVIOR CHANGE; CONDOM; COST EFFECTIVENESS ANALYSIS; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INTERVENTION STUDY; MASS MEDIUM; NEEDLE; POLICY; SEXUALLY TRANSMITTED DISEASE; TAX; UNITED STATES; VIRUS TRANSMISSION;

CONDOMS; COST-BENEFIT ANALYSIS; FEMALE; HEALTH EDUCATION; HEALTH PROMOTION; HIV INFECTIONS; HUMANS; INTERVENTION STUDIES; MASS MEDIA; NEEDLE-EXCHANGE PROGRAMS; PREVALENCE; PUBLIC POLICY; RISK-TAKING; SEXUALLY TRANSMITTED DISEASES; SOUTHEASTERN UNITED STATES; TAXES; WOMEN'S HEALTH;

EID: 33745654102     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.olq.0000221015.64056.ee     Document Type: Article

References (35)

1. Kirschenbaum H. Carl Rogers's life and work: An assessment on the 100th anniversary of his birth. J Couns Dev 2004; 82:116-124.
2. Skinner BF. Reflections on Behaviorism and Society. Englewood Cliffs, NJ: Prentice-Hall, 1978.
3. Karon JM, Fleming PL, Steketee RW, et al. HIV in the United States at the turn of the century: An epidemic in transition. Am J Public Health 2001; 91:1060-1068.
4. Cohen D, Wu S, Farley T. Comparing the cost-effectiveness of HIV prevention interventions. J Acquir Immun Defic Syndr 2004; 37:1404-1414.
5. Centers for Disease Control and Prevention. THREE: The Changing Epidemic. How Is CDC Responding? Available at: http://www.cdc.gov/ hiv/HIV_3rdDecade/ section3.htm. Accessed August 31, 2004.
6. Cohen DA, Farley TA, Bedimo-Etame JR, et al. Implementation of condom social marketing in Louisiana, 1993 to 1996. Am J Public Health 1999; 89:204-208.
7. Heimer R, Khoshnood K, Bigg D, et al. Syringe use and reuse: Effects of syringe exchange programs in four cities. J Acquir Immun Defic Syndr Hum Retrovirol 1998; 18(suppl 1):S37-S44.
8. Groseclose SL, Weinstein B, Jones TS, et al. Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers - Connecticut, 1992-1993. J Acquir Immun Defic Syndr Hum Retrovirol 1995; 10:82-89.
9. Alcohol policy and sexually transmitted disease rates - United States, 1981-1995. MMWR Morb Mortal Wkly Rep 2000; 49:346-349.
10. Dubois-Arber F, Jeannin A, Konings E, et al. Increased condom use without other major changes in sexual behavior among the general population in Switzerland. Am J Public Health 1997; 87:558-566.
11. Wendell DA, Cohen DA, LeSage D, et al. Street outreach for HIV prevention: Effectiveness of a state-wide programme. Int J STD AIDS 2003; 14:334-340.
12. Kelly JA, St. Lawrence JS, Diaz YE, et al. HIV risk behavior reduction following intervention with key opinion leaders of population: An experimental analysis. Am J Public Health 1991; 81:168-171.
13. Seage GR 3rd, Mayer KH, Wold C, et al. The social context of drinking, drug use, and unsafe sex in the Boston Young Men Study. J Acquir Immun Defic Syndr Hum Retrovirol 1998; 17:368-375.
14. Staton M, Leukefeld C, Logan TK, et al. Risky sex behavior and substance use among young adults. Health Soc Work 1999; 24:147-154.
15. Petty NM. Alcohol use in HIV patients: What we don't know may hurt us. Int J STD AIDS 1999; 10:561-570.
16. Basen-Engquist K, Coyle KK, Parcel GS, et al. Schoolwide effects of a multicomponent HIV, STD, and pregnancy prevention program for high school students. Health Educ Behav 2001; 28:166-185.
17. Nigeria using more condoms. Africa Health 1997; 19:3.
18. Kegeles SM, Hays RB, Coates TJ. The Mpowerment Project: A community-level HIV prevention intervention for young gay men. Am J Public Health 1996; 86:1129-1136.
19. Coyle SL, Needle RH, Normand J. Outreach-based HIV prevention for injecting drug users: A review of published outcome data. Public Health Rep 1998; 113(suppl 1):19-30.
20. Kelly JA, Murphy DA, Sikkema KJ, et al. Randomised, controlled, community-level HIV-prevention intervention for sexual-risk behaviour among homosexual men in U.S. cities. Community HIV Prevention Research Collaborative. Lancet 1997; 350:1500-1505.
21. Backer TE, Rogers EM. Diffusion of innovations theory and work-site AIDS programs. J Health Commun 1998; 3:17-28.
22. Cohen DA, Wu SY, Farley TA. Comparing the cost-effectiveness of HIV prevention interventions. J Acquir Immun Defic Syndr 2004; 37:1404-1414.
23. Weinstein M, Graham J, Siegel J, et al. Cost-effectiveness analysis of AIDS prevention programs: Concepts, complications, and illustration. In: Turner C, Miller H, Moses L, eds. AIDS: Sexual Behavior and Intravenous Drug Use. Washington, DC: National Academy Press, 1989:471-499.
24. Bedimo AL, Pinkerton SD, Cohen DA, et al. Condom distribution: A cost-utility analysis. Int J STD AIDS 2002; 13:384-392.
25. Cohen DA, Wu SY, Farley TF. Maximizing the Benefit: Estimating the Relative Cost-Effectiveness of HIV Prevention Interventions. Paper presented at the 16th biennial meeting of the International Society for Sexually Transmitted Disease Research (ISSTDR), 2003, Ottawa, Canada.
26. Holmberg SD. The estimated prevalence and incidence of HIV in 96 large U.S. metropolitan areas. Am J Public Health 1996; 86:642-654.
27. Lurie P, Gorsky R, Jones TS, et al. An economic analysis of needle exchange and pharmacy-based programs to increase sterile syringe availability for injection drug users. J Acquir Immun Defic Syndr Hum Retrovirol 1998; 18(suppl 1):S126-132.
28. Burris S, Vernick JS, Ditzler A, et al. The legality of selling or giving syringes to injection drug users. J Am Pharm Assoc (Wash) 2002; 42(suppl 2):S13-18.
29. Farley T, Niccolai L, Billeter M, et al. Attitudes and practices of pharmacy managers regarding needle sales to injection drug users. J Am Pharm Assoc 1999; 39:23-26.
30. Kelly JA, St. Lawrence JS, Stevenson LY, et al. Community AIDS/ HIV risk reduction: The effects of endorsements by popular people in three cities. Am J Public Health 1992; 82:1483-1489.
31. Centers for Disease Control and Prevention. BRFSS - Prevalence Data. Available at:http://apps.nccd.cdc.gov/brfss/list.asp?cat=AC&yr=2003& qkey=4413&state=All. Accessed December 8, 2004.
32. Holtgrave DR, Pinkerton SD. Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs. J Acquir Immun Defic Syndr Hum Retrovirol 1997; 16:54-62.
33. Pinkerton SD, Holtgrave DR, DiFranceisco WJ, et al. Cost-effectiveness of a community-level HIV risk reduction intervention. Am J Public Health 1998; 88:1239-1242.
34. Rojanapithayakorn W, Hanenberg R. The 100% condom program in Thailand. AIDS 1996, 10:1-7.
35. Chesson H, Harrison P, Kassler WJ. Sex under the influence: The effect of alcohol policy on sexually transmitted disease rates in the United States. J Law Econ 2000; XLIII:215-238.